Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Glendale, California and currently employs 4 full-time employees. The company went IPO on 2002-01-07. The firm is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.
IMMB stock price ended at $0 on 星期三, after rising NaN%
On the latest trading day Mar 25, 2026, the stock price of IMMB rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 62.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 5.0K shares were traded, amounting to a market value of approximately --.